Tag: lawsuits
-
YAZ / Yasmin / Ocella / Gianvi Blood Clot Lawsuits That Are Not Settled Yet: Number Increases, Indicating That These Legal Claims Continue To Be Filed In 2013
Bayer Has Paid $1.4 Billion In Settlements for Cases Involving Deep Vein Thrombosis (DVT) And/Or Pulmonary Embolism (PE), Also Called "Venous Clot Injuries" (Posted by Tom Lamb at DrugInjuryWatch.com)Previously, we reported that more than…
-
July 2013 Update: New FDA Action To Be Taken In Or About September On Issue Of Drug Label Revisions By Generic Manufacturers
Allowing Supplemental Applications For Proposed Labeling Changes Might End Federal Preemption Shield From Legal Liability That Came With Mensing Ruling (Posted by Tom Lamb at DrugInjuryWatch.com) ______________________________________________________________________________ UPDATE: The FDA’s long-awaited proposed rule on…
-
Summer 2013 Bayer Lawsuits Update: YAZ, Yasmin, Ocella, And Gianvi Lawsuits Continue To Be Settled, With New Cases Being Filed
Bayer Financial Report Shows That More Than 2,500 Venous / Blood Clot Cases (DVT and/or PE) Do Not Have Settlement Agreements As Of April 15, 2013 (Posted by Tom Lamb at DrugInjuryWatch.com)From the "Product-related litigations"…
-
Kidney Dialysis Anemia Drug Recall: Omontys: Hypersensitivity / Allergic Reactions And Anaphylaxis; Serious Side Effects With Some Being Fatal
Omontys: Deaths During Initial Injection Within 30 Minutes During Treatment Of Anemia Due To Chronic Kidney Disease In Hemodialysis Patients (Posted by Tom Lamb at DrugInjuryWatch.com)The Omontys (peginesatide) injection was approved in March 2012…
-
Pradaxa: February 2013 Update: Federal Court MDL Litigation Now Involves About 200 Lawsuits
This Number Of Pradaxa Cases Is About Ten Times What It Was When The Pradaxa MDL Was Created And Assigned To Judge Herndon In August 2012 (Posted by Tom Lamb at DrugInjuryWatch.com)As we reported…
-
Despite FDA Regulations, Generic Drug Labels Often Failed To Match Brand Name Drug Safety Warnings
Two-Thirds Of The Generics Did Not Have Identical Labeling, And Up To 9% Showed Differences Of More Than 10 Side Effects (Posted by Tom Lamb at DrugInjuryWatch.com) A disturbing new study about drug labeling for generic medications…
-
November 2012 Litigation And Settlements Update: YAZ, Yasmin, Ocella, And Gianvi Lawsuits
Bayer Has Settled Less Than Half The DVT And PE Blood Clot Claims Filed Or Cases Subject To Tolling Agreements (Posted by Tom Lamb at DrugInjuryWatch.com) In late October 2012 we received the Bayer Stockholders’ Newsletter…